2020
Form, Function, and Dysfunction: Airway Diseases Are Associated With Increased Risk for Rheumatoid Arthritis
Sauler M. Form, Function, and Dysfunction: Airway Diseases Are Associated With Increased Risk for Rheumatoid Arthritis. Arthritis & Rheumatology 2020, 72: 699-701. PMID: 31876099, PMCID: PMC7188593, DOI: 10.1002/art.41193.Commentaries, Editorials and Letters
2017
MIF and Pulmonary Disease
Baker T, Lee P, Sauler M. MIF and Pulmonary Disease. Progress In Inflammation Research 2017, 135-144. DOI: 10.1007/978-3-319-52354-5_8.ChaptersMacrophage migration inhibitory factorPulmonary diseaseRole of MIFMigration inhibitory factorInnate immune responseLung surface areaLung diseaseImmune responseProtective roleInhibitory factorMultifunctional cytokineLungOxidative stressDiseaseCritical regulatorExternal toxinsGas exchangeCytokinesPathogenesis
2015
Role of macrophage migration inhibitory factor in age-related lung disease
Sauler M, Bucala R, Lee PJ. Role of macrophage migration inhibitory factor in age-related lung disease. American Journal Of Physiology - Lung Cellular And Molecular Physiology 2015, 309: l1-l10. PMID: 25957294, PMCID: PMC4491511, DOI: 10.1152/ajplung.00339.2014.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsMacrophage migration inhibitory factorAge-related lung diseaseMigration inhibitory factorLung diseaseInhibitory factorChronic obstructive lung diseaseChronic lung diseaseObstructive lung diseaseCommon respiratory disorderPulmonary fibrosisClinical manifestationsProinflammatory cytokinesLung cancerRespiratory disordersImmune systemVariant allelesDiseaseHost factorsSuch diseasesPotent upstream regulatorUpstream regulatorPneumoniaFibrosisBody of literatureCytokines
2014
Oxidants in Acute and Chronic Lung Disease
Mannam P, Srivastava A, Sugunaraj JP, Lee PJ, Sauler M. Oxidants in Acute and Chronic Lung Disease. Journal Of Blood & Lymph 2014, 4: 1000128. PMID: 25705575, PMCID: PMC4335304, DOI: 10.4172/2165-7831.1000128.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsChronic obstructive pulmonary diseaseAcute lung injuryLung diseaseChronic lung diseaseObstructive pulmonary diseaseReactive oxygen speciesAnti-oxidant strategiesLung injuryPulmonary diseaseLung pathologyOxidant responsesConsistent benefitHomeostatic functionsBeneficial effectsAdverse effectsOxidant generationDiseaseBeneficial resultsOxygen speciesAcuteInjuryTherapyPathologyNovel areaImportant role
2012
Newly Recognized Occupational and Environmental Causes of Chronic Terminal Airways and Parenchymal Lung Disease
Sauler M, Gulati M. Newly Recognized Occupational and Environmental Causes of Chronic Terminal Airways and Parenchymal Lung Disease. Clinics In Chest Medicine 2012, 33: 667-680. PMID: 23153608, PMCID: PMC3515663, DOI: 10.1016/j.ccm.2012.09.002.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsParenchymal lung diseaseExposure-disease relationshipsLung diseaseTerminal airwaysDiffuse parenchymal lung diseaseWorld Trade Center disasterChronic formHigh indexNovel exposureDiseaseEnvironmental exposuresHealth investigatorsWorker surveillanceAirwayExposureEnvironmental causesPotential toxicityCliniciansSuspicionNylon flockBiomarkers
2011
Pulmonary Embolism in Older Patients
Mathur A, Sauler M, Pisani M. Pulmonary Embolism in Older Patients. Respiratory Medicine 2011, 133-153. DOI: 10.1007/978-1-60761-727-3_7.ChaptersVenous thromboembolic diseaseDeep vein thrombosisPulmonary embolismThromboembolic diseaseComplications of treatmentMiddle-aged subjectsHospital deathOlder patientsVein thrombosisSignificant morbidityGeriatric populationRisk factorsMedical conditionsEmbolismPatientsDiseaseDiagnosisDeathAgeTreatmentMorbidityThrombosisComplicationsPathophysiologyMajor studies